Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., ...

WATERTOWN, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to

Related Keywords

Peter Blume Jensen ,Alexandra Santos ,Ivana Magov ,Exchange Commission ,Amgen ,Vigil Neuroscience Inc ,Wheaton College ,Teva Pharmaceutical Industries Ltd ,Genetic Technologies Corporation ,Harvard University ,Acrivon Therapeutics Inc ,Drug Administration ,Suffolk University Law School ,Acrivon Predictive Precision Proteomics ,Vigil Neuroscience ,Teva Pharmaceutical Industries ,Aeglea Therapeutics ,Applied Genetic Technologies ,Suffolk University Law ,Fast Track ,Breakthrough Device ,Private Securities Litigation Reform Act ,Media Contacts ,Region ,